iShares U.S. Healthcare ETF (IYH)
IYH vs. FBT: Broad Healthcare ETF or Concentrated Biotech Play?
The iShares U.S. Healthcare ETF provides broad sector exposure with 100 holdings, while the First Trust NYSE Arca Biotechnology Index Fund focuses on a concentrated basket of 30 biotech stocks. The First Trust fund has delivered higher recent returns but experiences greater price volatility.
Which is the Better Choice for Healthcare Investors? IYH or BBH?
iShares U.S. Healthcare ETF provides broader exposure with 100 holdings compared to the 25 found in VanEck Biotech ETF VanEck Biotech ETF has delivered higher recent total returns but carries significantly greater historical price volatility iShares U.S. Healthcare ETF offers a higher dividend yield and lower five-year maximum drawdown for income-focused investors
Should You Invest in the iShares U.S. Healthcare ETF (IYH)?
Looking for broad exposure to the Healthcare - Broad segment of the equity market? You should consider the iShares U.S. Healthcare ETF (IYH), a passively managed exchange traded fund launched on June 12, 2000.
Should You Invest in the iShares U.S. Healthcare ETF (IYH)?
Launched on June 12, 2000, the iShares U.S. Healthcare ETF (IYH) is a passively managed exchange traded fund designed to provide a broad exposure to the Healthcare - Broad segment of the equity market.
Balboa Wealth Partners Acquires Shares of 44,382 iShares U.S. Healthcare ETF $IYH
Balboa Wealth Partners acquired a new position in shares of iShares U.S. Healthcare ETF (NYSEARCA:IYH) in the undefined quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor acquired 44,382 shares of the company's stock, valued at approximately $2,889,000. Balboa Wealth Partners owned about 0.08%
Okta, Phillips 66 And More: CNBC's 'Final Trades'
Okta shares rose 3% to close at $80.76 on Thursday while Phillips 66 shares gained 3.2% to settle at $178.34.
Should You Invest in the iShares U.S. Healthcare ETF (IYH)?
Launched on June 12, 2000, the iShares U.S. Healthcare ETF (IYH) is a passively managed exchange traded fund designed to provide a broad exposure to the Healthcare - Broad segment of the equity market.
IYH: Elevated Valuations And Slowing Growth Signal Subpar 2026 Returns
iShares U.S. Healthcare ETF receives a hold rating due to concerning signals from its top holdings and elevated valuations. IYH's heavy concentration in LLY, JNJ, and ABBV exposes the fund to slowing growth, regulatory pressures, and high forward P/E ratios. GLP-1 market risks, muted growth at JNJ, and ABBV's patent expirations threaten IYH's forward performance and capital appreciation.
Should You Invest in the iShares U.S. Healthcare ETF (IYH)?
Designed to provide broad exposure to the Healthcare - Broad segment of the equity market, the iShares U.S. Healthcare ETF (IYH) is a passively managed exchange traded fund launched on June 12, 2000.
Healthcare ETF (IYH) Hits New 52-Week High
IYH hits a 52-week high as healthcare gains momentum, lifted by sector strength and rising investor interest in safety and AI-driven tailwinds.
Creative Planning Purchases 3,573 Shares of iShares U.S. Healthcare ETF $IYH
Creative Planning raised its position in iShares U.S. Healthcare ETF (NYSEARCA:IYH) by 7.4% in the undefined quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 51,802 shares of the company's stock after purchasing an additional 3,573 shares during the quarter. Creative Planning owned
D.A. Davidson & CO. Cuts Position in iShares U.S. Healthcare ETF $IYH
D.A. Davidson and CO. cut its stake in iShares U.S. Healthcare ETF (NYSEARCA:IYH) by 6.2% in the undefined quarter, according to its most recent disclosure with the SEC. The institutional investor owned 5,014 shares of the company's stock after selling 331 shares during the period. D.A. Davidson and CO.'s holdings in iShares
Trade Truce Hope: How US-China Talks Could Boost Healthcare ETFs
Hopes of a U.S.-China trade truce are lifting sentiment for healthcare ETFs like XLV, IYH, and VHT, which could gain from easing tariffs and lower costs.
Should You Invest in the iShares U.S. Healthcare ETF (IYH)?
The iShares U.S. Healthcare ETF (IYH) was launched on June 12, 2000, and is a passively managed exchange traded fund designed to offer broad exposure to the Healthcare - Broad segment of the equity market.
IYH: Healthcare Dashboard For September
This article provides a top-down view of the healthcare sector based on fundamental metrics. Healthcare providers and pharmaceutical/biotechnology subsectors are undervalued versus 11-year averages. Fast facts on iShares U.S. Healthcare ETF, an alternative to XLV.
As the Market Rotates, This Healthcare ETF Is Leading the Way
Over the past month, the market has undergone a rotation that's seen tech sell-off and defensive sectors like healthcare reap the rewards. The jury remains out on whether this shift indicates a more inclusive rally or if it should raise questions about the bull market's footing.
Should You Invest in the iShares U.S. Healthcare ETF (IYH)?
The iShares U.S. Healthcare ETF (IYH) was launched on June 12, 2000, and is a passively managed exchange traded fund designed to offer broad exposure to the Healthcare - Broad segment of the equity market.
IYH: An Aggressive Positioning On The U.S. Healthcare Industry
IYH is a buy for bullish investors in U.S. healthcare, offering strong exposure to industry leaders benefiting from innovation, aging populations, and digital transformation. The ETF's concentrated portfolio targets pharmaceuticals, equipment, and biotechnology, positioning it to capitalize on key market growth trends and outperform peers if the sector thrives. IYH boasts the lowest expense ratio among peers and has outperformed over 5 years, but its high concentration increases risk compared to more diversified alternatives like VHT.
Should You Invest in the iShares U.S. Healthcare ETF (IYH)?
The iShares U.S. Healthcare ETF (IYH) was launched on 06/12/2000, and is a passively managed exchange traded fund designed to offer broad exposure to the Healthcare - Broad segment of the equity market.
IYH: Healthcare Dashboard For April
This article provides a top-down analysis of the healthcare sector, focusing on value, quality and momentum metrics. Current data shows no healthcare subsector is particularly attractive; the least compelling one is pharmaceuticals/biotechnology, with both value and quality scores significantly below the baseline. iShares U.S. Healthcare ETF (IYH) has little to show compared to Health Care Select Sector SPDR ETF (XLV), which offers a better historical return, lower expense ratio, and higher liquidity.